LRRC15 and cancer: Another study revealed that the infiltration of CAFs expressing leucine-rich repeat-containing 15 (LRRC15), whose expression was induced by TGF-β, correlated with poor response to ICB therapy across multiple cancer types (Dominguez et al, 2020).